Main useUsed for selected breast, stomach, lung and other solid cancers meeting specific HER2 criteria.A brief overview of Japanese approved uses. Check the PMDA label below for product-specific conditions.
- Japan product name
- エンハーツ点滴静注用100mg
- Brand
- Enhertu
- Generic name
- Trastuzumab deruxtecan
- Japanese generic name
- トラスツズマブ デルクステカン
- Chinese name
- 曲妥珠单抗德鲁斯特康
- Marketing authorization holder
- 第一三共株式会社
- Strengths
- 100 mg
- Dosage form
- IV infusion
- Therapeutic area
- Cancer care
- Regulatory status
- Rx
- Label updated
- 2026-09-16
- TOKYO MEDI verified
- 2026-09-22
Official source
These links go directly to PMDA records for this Japanese product. Professional and patient-facing sources are separated.